NKGNW logo

NKGen Biotech Warrants (NKGNW) Company Overview

Profile

Full Name:

NKGen Biotech, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Indexes:

Not included

Website:

http://nkgenbiotech.com

Description:

NKGen Biotech, Inc. operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. Its lead products include SNK01, an autologous NK cell therapy candidate treatment for neurodegenerative diseases; and SNK02, an allogeneic NK cell therapy, which is in Phase 1 clinical trials for refractory solid tumors. The company has a license agreement with NKMAX. The company was formerly known as NKMAX America, Inc. NKGen Biotech, Inc. was founded in 2017 and is headquartered in Santa Ana, California.

Key Details

Price

$0.04

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(-100.00% YoY)

Annual EPS

-

PE Ratio

-

Annual ROE

141.34%

Annual Debt To Equity

-0.34

Beta

-4.17

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with NKGNW included

Stocks cheaper than 1 dollar
US stocks
Healthcare sector
All stocks
Biotechnology industry
Stocks with low beta
NASDAQ earnings calendar
Stocks below SMA 200
Biggest stock losers today

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$0.04
NKGNW price is $0.04

Price All-time High

$0.13
NKGNW price is currently -68.93% below its historical high of $0.13

Price Analysts Target

-
NKGNW price consensus analysts' forecast is unknown

Price Most Recent Change

-40.65%
NKGNW price was down -40.65% on Feb 28, 2025

Price YTD Change

-59.7%
NKGNW price is down -59.7% since January 1st

Price 3-Year Change

-
NKGNW price 3-year change is unknown

Market cap

Market Cap

-
NKGNW market capitalization value is unknown

Market Cap 3-Year Change

-
NKGNW market capitalization 3-year change is unknown

Market Cap All-time High

-
NKGNW market capitalization all-time high is unknown

Market Cap Sector Rank

-
NKGNW market capitalization is unknown

Technical

Beta

-4.17
NKGNW beta is -4.17

200-day SMA

$0.07
NKGNW price is currently -41.51% below its 200-day simple moving average

14-day RSI

41.07
NKGNW 14-day relative strength index is 41.07

30-day Relative Volume

1.32
NKGNW 30-day relative volume is 1.32

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$0.00
NKGNW annual revenue is $0.00

Annual Revenue Analysts Estimate

-
NKGNW annual revenue consensus analysts' forecast is unknown

Annual Revenue 1-Year Change

-100%
NKGNW annual revenue is down -100% year-on-year

Annual Revenue Sector Rank

1.13%
NKGNW annual revenue is higher than 1.13% of companies in Healthcare sector

Profit

Annual Gross Profit

$0.00
NKGNW annual gross profit is $0.00

Annual Gross Margin

-
NKGNW annual gross profit margin value is unknown

Annual Operating Profit

-$29.75 M
NKGNW annual operating income is -$29.75 million

Annual Operating Margin

-
NKGNW annual operating profit margin value is unknown

Annual Net Income

-$82.95 M
NKGNW annual net profit is -$82.95 million

Annual Net Margin

-
NKGNW annual net profit margin value is unknown

EPS

Annual EPS

-
NKGNW annual earnings per share value is unknown

Annual EPS Analysts Estimate

-
NKGNW annual earnings per share consensus analysts' forecast is unknown

Annual EPS 1-Year Change

-
NKGNW annual earnings per share 1-year change is unknown

Annual EPS Sector Rank

-
NKGNW annual earnings per share is unknown

ROA & ROE

Annual ROA

-503.33%
NKGNW annual return on assets is -503.33%

Annual ROE

141.34%
NKGNW annual return on equity is 141.34%

EBIT & EBITDA

Annual EBIT

-$82.20 M
NKGNW annual earnings before interest & taxes is -$82.20 million

Annual EBITDA

-$29.47 M
NKGNW annual EBITDA is -$29.47 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
NKGNW price to earnings ratio value is unknown

PE Ratio Sector Rank

-
NKGNW price to earnings ratio is unknown

PB Ratio

PB Ratio

-
NKGNW price to book ratio value is unknown

PB Ratio Sector Rank

-
NKGNW price to book ratio is unknown

PS Ratio

PS Ratio

-
NKGNW price to sales ratio value is unknown

PS Ratio Sector Rank

-
NKGNW price to sales ratio is unknown

Enterprise value

Enterprise Value

-
NKGNW enterprise value value is unknown

Enterprise Value Sector Rank

-
NKGNW enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
NKGNW EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
NKGNW EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

0.05
NKGNW annual current ratio is 0.05

Annual Quick Ratio

-
NKGNW annual quick ratio value is unknown

Leverage

Annual Debt To Equity

-0.34
NKGNW annual debt to equity ratio is -0.34

Annual Interest Coverage Ratio

-110.34
NKGNW annual interest coverage ratio is -110.34

Risk & Stability

Piotroski F-Score

-
NKGNW piotroski f-score value is unknown

Altman Z-Score

-
NKGNW altman z-score value is unknown

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$16.48 M
NKGNW annual total assets is $16.48 million

Annual Non Current Assets

$14.55 M
NKGNW annual long term assets is $14.55 million

Annual Current Assets

$1.93 M
NKGNW annual total current assets is $1.93 million

Annual Cash & Cash Equivalents

$26.00 K
NKGNW annual cash & cash equivalents is $26.00 thousand

Equity

Annual Book Value

-$58.78 M
NKGNW annual book value is -$58.78 million

Annual Working Capital

-$37.52 M
NKGNW annual working capital is -$37.52 million

Liabilities

Annual Total Liabilities

$75.17 M
NKGNW annual total liabilities is $75.17 million

Annual Total Long Term Liabilities

$35.72 M
NKGNW annual total long term liabilities is $35.72 million

Annual Current Liabilities

$39.45 M
NKGNW annual total current liabilities is $39.45 million

Annual Accounts Payable

$11.04 M
NKGNW annual accounts payable is $11.04 million

Debt

Annual Total Debt

$19.92 M
NKGNW annual total debt is $19.92 million

Annual Total Debt 1-Year Change

+65.54%
NKGNW annual total debt is up +65.54% year-on-year

Annual Long Term Debt

$9.93 M
NKGNW annual long term debt is $9.93 million

Annual Short Term Debt

$9.99 M
NKGNW annual short term debt is $9.99 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$29.75 M
NKGNW annual total expenses is $29.75 million

Annual Operating Expenses

$29.75 M
NKGNW annual total operating expenses is $29.75 million

Annual Cost Of Goods Sold

$0.00
NKGNW annual cost of goods sold is $0.00

Annual SGA

$14.08 M
NKGNW annual SGA is $14.08 million

Annual D&A

$1.20 M
NKGNW annual depreciation & amortization is $1.20 million

Annual Interest Expense

$745.00 K
NKGNW annual interest expense is $745.00 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$21.95 M
NKGNW annual cash flow from operations is -$21.95 million

Annual CFO 1-Year Change

+2.7%
NKGNW annual cash flow from operations is up +2.7% year-on-year

Annual CFI

-$48.00 K
NKGNW annual cash flow from investing activities is -$48.00 thousand

Annual CFI 1-Year Change

+70.55%
NKGNW annual cash flow from investing activities is up +70.55% year-on-year

Annual CFF

$22.16 M
NKGNW annual cash flow from financing activities is $22.16 million

Annual CFF 1-Year Change

-1.47%
NKGNW annual cash flow from financing activities is down -1.47% year-on-year

Free CashFlow

Annual FCF

-$22.00 M
NKGNW annual free cash flow is -$22.00 million

Annual FCF 1-Year Change

+3.19%
NKGNW annual free cash flow is up +3.19% year-on-year

CAPEX

Annual CAPEX

$48.00 K
NKGNW annual capital expenditures is $48.00 thousand

Annual CAPEX 1-Year Change

-70.55%
NKGNW annual capital expenditures is down -70.55% year-on-year

Institutional Ownership

Similar stocks

FAQ

  • What is the ticker symbol for NKGen Biotech Warrants?
  • Does NKGen Biotech Warrants pay dividends?
  • What sector is NKGen Biotech Warrants in?
  • What industry is NKGen Biotech Warrants in?
  • What country is NKGen Biotech Warrants based in?
  • Is NKGen Biotech Warrants in the S&P 500?
  • Is NKGen Biotech Warrants in the NASDAQ 100?
  • Is NKGen Biotech Warrants in the Dow Jones?
  • When does NKGen Biotech Warrants report earnings?

What is the ticker symbol for NKGen Biotech Warrants?

The ticker symbol for NKGen Biotech Warrants is NASDAQ:NKGNW

Does NKGen Biotech Warrants pay dividends?

No, NKGen Biotech Warrants does not pay dividends

What sector is NKGen Biotech Warrants in?

NKGen Biotech Warrants is in the Healthcare sector

What industry is NKGen Biotech Warrants in?

NKGen Biotech Warrants is in the Biotechnology industry

What country is NKGen Biotech Warrants based in?

NKGen Biotech Warrants is headquartered in United States

Is NKGen Biotech Warrants in the S&P 500?

No, NKGen Biotech Warrants is not included in the S&P 500 index

Is NKGen Biotech Warrants in the NASDAQ 100?

No, NKGen Biotech Warrants is not included in the NASDAQ 100 index

Is NKGen Biotech Warrants in the Dow Jones?

No, NKGen Biotech Warrants is not included in the Dow Jones index

When does NKGen Biotech Warrants report earnings?

The date for NKGen Biotech Warrants's next earnings report has not been announced yet